Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.27B |
| 2 |
QXO
QXO Inc
QXO
|
+$1.14B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 4 |
Thermo Fisher Scientific
TMO
|
+$505M |
| 5 |
Walt Disney
DIS
|
+$502M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$938M |
| 3 |
Microsoft
MSFT
|
+$734M |
| 4 |
McDonald's
MCD
|
+$609M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$544M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.37% |
| 2 | Healthcare | 3.33% |
| 3 | Consumer Discretionary | 2.43% |
| 4 | Financials | 2.27% |
| 5 | Industrials | 1.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11801
PUT
QuinStreet
QNST
$1.18B
| $44.8K | ﹤0.01% |
2,700
-6,500
| -71% | -$113K |
|
|
CMRX
11802
PUT
DELISTED
Chimerix, Inc.
CMRX
| $44.8K | ﹤0.01% |
51,100
+44,300
| +651% | +$42K |
|
11803
CALL
Celularity
CELU
$20.1M
| $44.8K | ﹤0.01% |
14,300
+5,800
| +68% | +$20.1K |
|
11804
CALL
Aegon
AEG
$14B
| $44.7K | ﹤0.01% |
7,300
+5,700
| +356% | +$36K |
|
11805
Cognition Therapeutics
CGTX
$96M
| $44.7K | ﹤0.01% |
+26,950
| New | +$53.7K |
|
11806
CALL
Getty Images
GETY
$129M
| $44.7K | ﹤0.01% |
13,700
+4,500
| +49% | +$16.8K |
|
|
INVX
11807
PUT
Innovex International
INVX
$2.18B
| $44.6K | ﹤0.01% |
2,400
-5,500
| -70% | -$107K |
|
|
OGI
11808
Organigram Holdings
OGI
$173M
| $44.6K | ﹤0.01% |
+28,975
| New | +$52.6K |
|
11809
CALL
Thryv Holdings
THRY
$96M
| $44.5K | ﹤0.01% |
2,500
+1,500
| +150% | +$31.8K |
|
11810
CALL
Verrica Pharmaceuticals
VRCA
$85.4M
| $44.5K | ﹤0.01% |
+610
| New | +$46.9K |
|
11811
CALL
Kyverna Therapeutics
KYTX
$505M
| $44.3K | ﹤0.01% |
5,900
+5,700
| +2,850% | +$87.1K |
|
|
DADA
11812
PUT
DELISTED
Dada Nexus
DADA
| $44.2K | ﹤0.01% |
35,100
-16,500
| -32% | -$29.7K |
|
11813
PUT
Universal Electronics
UEIC
$67.9M
| $44.2K | ﹤0.01% |
3,800
-200
| -5% | -$2.24K |
|
11814
CALL
Dakota Gold
DC
$836M
| $44.1K | ﹤0.01% |
17,300
+11,400
| +193% | +$30.3K |
|
11815
AudioEye
AEYE
$100M
| $44.1K | ﹤0.01% |
2,505
-49,401
| -95% | -$873K |
|
11816
PUT
Cass Information Systems
CASS
$748M
| $44.1K | ﹤0.01% |
1,100
+200
| +22% | +$8.71K |
|
11817
PUT
Astronics
ATRO
$4.61B
| $44.1K | ﹤0.01% |
2,640
+600
| +29% | +$9.31K |
|
|
MAMO
11818
Massimo Group
MAMO
$44.1M
| $44.1K | ﹤0.01% |
+11,748
| New | +$45.7K |
|
11819
PUT
Gorman-Rupp
GRC
$2.13B
| $44.1K | ﹤0.01% |
1,200
+1,000
| +500% | +$35.3K |
|
|
BQ
11820
Boqii Holding Ltd
BQ
$8.19M
| $44K | ﹤0.01% |
8,350
+6,221
| +292% | +$23K |
|
|
VLRS
11821
PUT
Controladora Vuela Compania de Aviacion
VLRS
$906M
| $43.9K | ﹤0.01% |
6,900
+1,600
| +30% | +$12.3K |
|
|
SPRB
11822
Spruce Biosciences
SPRB
$151M
| $43.9K | ﹤0.01% |
1,130
-42
| -4% | -$2.25K |
|
|
SASR
11823
CALL
DELISTED
Sandy Spring Bancorp Inc
SASR
| $43.8K | ﹤0.01% |
1,800
+800
| +80% | +$17.8K |
|
11824
CALL
iShares Europe ETF
IEV
$1.7B
| $43.8K | ﹤0.01% |
+800
| New | +$44.7K |
|
11825
CALL
Monte Rosa Therapeutics
GLUE
$1.32B
| $43.8K | ﹤0.01% |
11,700
-3,600
| -24% | -$18.4K |
|
Similar funds
Ken Griffin's Q2 2024 Portfolio in Review
As of Q2 2024, Ken Griffin held 15,899 positions worth $494B, down 4.7% from $518B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Ken Griffin withdrew a net $42.4B in Q2 2024, closing 1,760 positions and reducing 6,731 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $1.46B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Ken Griffin opened a new position in Carrier Global worth $140M.
- Ken Griffin's largest Q2 2024 buy was Carrier Global: 2,220,323 shares worth $140M.
- Ken Griffin added most to Invesco QQQ Trust in Q2 2024, an estimated $1.27B increase.
- Ken Griffin's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $938M.
- Ken Griffin fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.46B.
- Ken Griffin's ten largest holdings make up 29% of its $494B portfolio in Q2 2024.
- Ken Griffin opened 1,434 new positions and closed 1,760 in Q2 2024.
- Ken Griffin's portfolio value fell 4.7% quarter-over-quarter to $494B.
Based on Citadel Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.